The investigation centers on whether Lincoln’s leadership misled stakeholders regarding the company's operational health. On August 10, 2026, the company announced that new student starts had risen by only 1%, a figure that management attributed to system-wide issues affecting every program. During the subsequent earnings call, executives admitted that this lower volume directly inflated the cost per start.

Investors reacted sharply to the news, sending the stock price down $10.22 to close at $30.77 per share. Pomerantz LLP, a firm specializing in securities class litigation, is now reviewing the company’s conduct to determine if officers or directors breached fiduciary duties. Investors who held shares during this period are encouraged to contact Danielle Peyton at the firm to discuss potential claims.